Neuroimmunology Program - IDIBAPS

News

  • “Brain atrophy in MS ¿are we ready for NEDA-4?.”

    Magi Andorrà, our engineer will discuss this topic at our weekly meeting.

  • Voxeleron Awarded NIH SBIR Grant for Device-independent Retinal Image Analysis Software Platform. Collaboration with UCSF and IDIBAPS

    Voxeleron announced today that it has been awarded a Phase I Small Business Innovation Research (SBIR) grant for $222,991 from the National Institutes of Health's (NIH) National Center for the Advancement of Translational Sciences (NCATS) to further develop device-independent retinal image analysis software.

  • II Update on Optic Nerve Degeneration. A European Network. 17-18 March 2017, Barcelona, Spain

    ORGANIZED BY
    Dr. Elena H Martinez-Lapiscina & Dr. Bernardo Sanchez-Dalmau 
    Visual Pathway Lab, Hospital Clinic of Barcelona & Institute of Biomedical Sciences August Pi i Sunyer 

    VISUAL PATHWAY LAB

    MISSION
    EUPON inspires European multidisciplinary collaborations to further the knowledge in ophthalmological and neurological optic nerve pathologies.

    VISION
    To be a European reference and lead international efforts in diagnostic, therapeutic and research strategies involving optic nerve.

    TARGET AUDIENCE
    Opthalmologist, Neurologist, Engineers working in Biomedicine, Optometrists, Nurses

  • IDIBAPS shares one milion euros to develop a project on Multiple Sclerosis

    The purpose of this research is to monitor molecular changes experienced by retinal neurons in patients with MS. The goal is focused on providing information that could allow, on the one hand, developing new therapies, and on the other hand, controlling the therapeutic response of patients to current drugs. All this is expected to be achieved through an optical device using Raman spectroscopy, a technique that measures molecular changes occured in the retina of patients quickly and without using any contrast. While it is known that in MS inflammatory damage of neurons leads to neuronal loss, the relationship between these two mechanisms is not fully known. And it is precisely the understanding of this relationship that could help driving therapeutical efforts and the phenomenon on which the winning project focuses its determination. Dra. Elena H. Martínez-Lapiscina was the student who got the best score of more than 10,000  applicants Resident Intern examination (MIR) in 2008. She combined her residency at the Hospital de Navarra with a PhD cum laude on the effects of healthy eating on cognitive function . She started on 2012 a Fellowship in medical image at the Neuroimmunology center with Dr. Pablo Villoslada. Her research focuses on the cause and development of biomarkers for MS and neuromyelitis optica. A prestigious grant GMSI is an initiative launched by the pharmaceutical company Merck KGaA. In this 32th edition, there have been awarded four of the 260 research projects submitted. A scientific committee has analyzed the proposals and has chosen four winners based on their relevance to clinical practice, innovation, feasibility and practical utility. 

  • Two communications by Elena Hernández Martínez-Lapiscina at the 13th ISNI Congress, Jerusalem

    Two communications from the Visual Pathway Lab, Neuroimmunology Program, have been presented at the 13th International Congress of Neuroimmunology hold in Jerusalem last week of setember. 

    Retinal atrophy is more prominent in the early ohases of multiple sclerosis and is associated with disease activity: a cohort study. As an oral communication and poster.

    The role of multifocal visual evoked potentials in undesrtanding disability in multiple sclerosis. As a poster.

  • Molecular Imaging of the human retina by Raman Spectroscopy

    Objective: to develop a system for molecular imaging of human retina by coupling Raman Spectroscopy to a confocal Scanning Laser Ophthalmoscope (RScSLO).

    Author Block: Elena H. Martinez-Lapiscina, Oscar Batet, Antoni Gonzalez, Albert Campos, Iker Bilbao, Dídac Perez, Elena Fraga-Pumar, Rubén Torres-Torres, Yago Rossello, Bernardo Sanchez-Dalmau, Ivan Amat-Roldan, Pablo Villoslada, Barcelona, Spain, San Francisco, CA, USA

  • Improved analysis framework for MS connectomes: Magí Andorrà

    Magí Andorrà presenta una comunicación en el ISMRM Italian Chapter en Verona el próximo 17 de Abril de 2015.